GlassScriptPhysician profile
Loren A Elchik
NPI 1790326387
$1,130.21
in general payments reported to CMS, 2019-2025
14 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.69 · 2023: $406 · 2024: $402 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $228.52 | 2023-2024 | Puraply |
| Ars Pharmaceuticals Operations, INC. | $125.01 | 2025 | Neffy |
| Amgen INC. | $107.70 | 2025 | Evenity |
| Phathom Pharmaceuticals, INC. | $95.76 | 2024 | Voquezna |
| Sage Therapeutics, LLC | $94.50 | 2024 | |
| Smith+Nephew, INC. | $92.30 | 2023-2024 | Oasis, Grafix Pl, Duramax S Silicone Super Absorbent Dressing |
| Vertex Pharmaceuticals Incorporated | $76.00 | 2025 | |
| Sanofi-Aventis U.S. LLC | $73.07 | 2024 | |
| Abbvie INC. | $70.40 | 2024 | |
| Convatec INC. | $61.36 | 2023 | |
| Molnlycke Health Care US, LLC | $56.17 | 2023 | Mepitel One, Tubigrip, Exufiber Ag+ |
| Kci USA, INC. | $18.13 | 2023 | Promogran Prisma, V.A.C. Dermatac, Activ.A.C. |
| Hartmann USA, INC. | $17.60 | 2023 | Zetuvit Plus |
| Medela LLC | $13.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loren Elchik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.